Digoxin and Nicardipine Interaction

Drug interaction information between Digoxin and Nicardipine.

Digoxin and Nicardipine have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Digoxin and Nicardipine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Digoxin

Cardiac Glycoside

Drug B

Nicardipine

Calcium Channel Blocker

How They Interact

Nicardipine may cause digoxin to build up in your bloodstream by changing how your body handles the drug.

FDA Label Information

Digoxin Some calcium blockers may increase the concentration of digitalis preparations in the blood. Nicardipine hydrochloride capsules usually do not alter the plasma levels of digoxin; however, serum digoxin levels should be evaluated after concomitant therapy with nicardipine hydrochloride capsules are initiated.

Digoxin Also Interacts With

View all Digoxin interactions →

Frequently Asked Questions

What SPL severity band is on file for Digoxin + Nicardipine?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Digoxin has 120 labeled pairs on file vs Nicardipine's 14. In the major band specifically: Digoxin has 2 (also Posaconazole); Nicardipine has 1.

What mechanism field is on file for Digoxin and Nicardipine?

Nicardipine may cause digoxin to build up in your bloodstream by changing how your body handles the drug.

Digoxin carries more major-labeled pairs than Nicardipine

SPL source-record counts only. This page's band is major · classes on file: Digoxin (Cardiac Glycoside); Nicardipine (Calcium Channel Blocker).

Digoxin has 2 major-labeled pairs vs Nicardipine's 1.

Digoxin

2 major · 13 moderate · 105 minor · 120 total

Nicardipine

1 major · 2 moderate · 11 minor · 14 total

Nicardipine has no other major-band peer in this dataset besides Digoxin.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.